SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-001624
Filing Date
2020-02-27
Accepted
2020-02-27 16:06:40
Documents
90
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rigl-20191231x10k.htm 10-K 3222438
2 EX-4.1 rigl-20191231ex41b54a47f.htm EX-4.1 26466
3 EX-10.10 rigl-20191231ex1010c0c93.htm EX-10.10 26021
4 EX-23.1 rigl-20191231ex2316803ff.htm EX-23.1 12192
5 EX-31.1 rigl-20191231ex311cee2ad.htm EX-31.1 12468
6 EX-31.2 rigl-20191231ex312e13011.htm EX-31.2 12495
7 EX-32.1 rigl-20191231ex32169dd22.htm EX-32.1 8709
8 GRAPHIC rigl20191231x10k001.jpg GRAPHIC 97356
9 GRAPHIC rigl20191231x10k002.jpg GRAPHIC 20129
  Complete submission text file 0001558370-20-001624.txt   11592316

Data Files

Seq Description Document Type Size
10 EX-101.INS rigl-20191231.xml EX-101.INS 2615817
11 EX-101.SCH rigl-20191231.xsd EX-101.SCH 69995
12 EX-101.CAL rigl-20191231_cal.xml EX-101.CAL 65789
13 EX-101.DEF rigl-20191231_def.xml EX-101.DEF 256122
14 EX-101.LAB rigl-20191231_lab.xml EX-101.LAB 662482
15 EX-101.PRE rigl-20191231_pre.xml EX-101.PRE 474135
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 20661982
SIC: 2834 Pharmaceutical Preparations